Group 1 - A total of 83 stocks experienced block trades in the A-share market on September 18, with a total transaction value of 11.257 billion yuan [1] - The top three stocks by transaction value were Pudong Development Bank (6.368 billion yuan), Shenghong Technology (3.073 billion yuan), and Haoyuan Pharmaceutical (276 million yuan) [1] - Among the stocks, 21 were traded at par, 8 at a premium, and 54 at a discount; the highest premium rates were for Bangyan Technology (12.72%), Pudong Development Bank (3.29%), and Huayu Pharmaceutical-W (2.99%) [1] Group 2 - The top stocks by institutional buy amounts included Shenghong Technology (2.499 billion yuan), Dameng Data (70.342 million yuan), and Yinzhijie (54.357 million yuan) [1] - The top stocks by institutional sell amounts were Sanhua Intelligent Controls (9.11 million yuan), New Industry (7.968 million yuan), and Hailiang Co. (4.9551 million yuan) [2]

Group 1 - On September 18, a total of 116,200 shares of New Industry were traded, with a transaction value of 7.9678 million yuan, accounting for 3.21% of the total transaction value for the day [1] - The transaction price was 68.57 yuan, which remained stable compared to the market closing price of 68.57 yuan [1][2] - The trading involved institutional buyers and sellers, indicating a significant level of interest from professional investors [2]

Group 1 - The exhibition "Awakening the Memory of Liulin" aims to promote community engagement in urban development and showcase the transformation of the Liulin area [1] - The exhibition is structured around three main themes: historical culture, the "Erliao" architecture, and the comparison of old and new [3][4] - Historical artifacts displayed in the exhibition connect the past with the present, highlighting the industrial heritage of the Liulin area, which began with the establishment of the Tianjin Paper Factory in 1937 [4][6] Group 2 - The "Erliao" facility, established in 1956, has undergone various functional transformations and is now a creative industry center, reflecting the evolution of the area [6] - The renovation of historical buildings is guided by the principle of "developing while protecting," aiming to make cultural heritage accessible to the public [6][11] - The cultural arts center has hosted various events, enhancing community interaction and providing a platform for local businesses and artists [9] Group 3 - The integration of modern container architecture with historical buildings creates a unique urban landscape, fostering a vibrant environment for startups and cultural activities [9] - The company plans to continue developing cultural consumption scenes and establishing a cultural identity for the region through ongoing activities and partnerships [11]

Group 1 - Guangdong Zhanxin Industry Venture Capital Fund was established on September 15 with a total investment of 3 billion RMB, focusing on private equity investment, investment management, and asset management [1] - The fund is backed by several partners including Guangdong New Energy Storage Industry Investment Fund, ICBC Capital Management, and Guangdong Energy Group [1] - The Guangdong Provincial State-owned Assets Supervision and Administration Commission plans to increase investments in strategic emerging industries and high-tech enterprises, with a total subscription scale of approximately 70 billion RMB for various funds [1] Group 2 - "Strategic Emerging Industries" are characterized by significant technological breakthroughs, high market demand potential, low resource consumption, and substantial employment opportunities [2] - These industries include seven major sectors: new generation electronic information, digital and fashion, high-end equipment, green and low-carbon, new materials, biomedicine and health, and marine economy [2] - The sectors encompass 20 major clusters such as semiconductors, artificial intelligence, renewable energy, and high-performance materials [2]

Core Insights - The State-owned Assets Supervision and Administration Commission (SASAC) emphasizes the focus of central enterprises on nine strategic emerging industries and six future industries, indicating a significant shift in investment strategy [1] - Since the beginning of the 14th Five-Year Plan, central enterprises have invested 8.6 trillion yuan in strategic emerging industries, marking a substantial increase compared to the 13th Five-Year Plan [1] - There has been notable acceleration in development within sectors such as integrated circuits, biotechnology, and new energy vehicles, alongside breakthroughs in cutting-edge fields like humanoid robots and superconducting quantum computing [1] - The industrial foundation in areas like industrial mother machines and new materials has been strengthened, showcasing a new pattern of industry development characterized by tiered expansion and collaborative progress [1]

天眼查工商信息显示，9月15日，广东战新产业创业投资基金合伙企业（有限合伙）成立，执行事务合 伙人为广东能源集团产业投资私募基金管理有限公司、工银资本管理有限公司，出资额30亿人民币，经 营范围为以私募基金从事股权投资、投资管理、资产管理等活动。合伙人信息显示，该基金由广东新型 储能产业投资基金合伙企业（有限合伙）、工银金融资产投资有限公司、广东储能产业发展有限公司、 工银资本管理有限公司、广东能源集团产业投资私募基金管理有限公司共同出资。 ...

Core Viewpoint - The company New Industry (300832) has received a medical device registration certificate from the Guangdong Provincial Drug Administration for a cardiac-type fatty acid binding protein assay kit, which is intended for the auxiliary diagnosis of acute myocardial infarction [1] Group 1 - The product is named "Cardiac-type Fatty Acid Binding Protein Assay Kit (Latex Immunoturbidimetric Method)" [1] - The assay kit is used for the quantitative measurement of cardiac-type fatty acid binding protein levels in human serum or plasma [1] - The clinical application of the product is specifically for assisting in the diagnosis of acute myocardial infarction [1]

格隆汇9月16日丨新产业(300832.SZ)公布，收到了广东省药品监督管理局颁发的1项《医疗器械注册 证》，产品名称：心脏型脂肪酸结合蛋白测定试剂盒（胶乳免疫比浊法）。截至目前，公司已先后取得 73项生化试剂《医疗器械注册证》（共107个注册证）。以上试剂及仪器新产品医疗器械注册证的取 得，丰富了公司生化检测产品中"心血管及心肌标志物"项目类别，将对公司发展具有正面影响，但对近 期的生产经营和业绩不会产生重大影响，敬请投资者给予关注并注意投资风险。 ...

每经头条（nbdtoutiao）——海拔4306米现"秦始皇密令"，获官方"身份认定"！古文字学家刘钊：秦人 寻仙采药足迹确至青藏高原 （记者 张明双） 每经AI快讯，新产业（SZ 300832，收盘价：68.88元）9月16日晚间发布公告称，近日，深圳市新产业 生物医学工程股份有限公司收到了广东省药品监督管理局颁发的1项《医疗器械注册证》。产品名称 为"心脏型脂肪酸结合蛋白测定试剂盒"。 2025年1至6月份，新产业的营业收入构成为：体外诊断占比99.84%，其他业务占比0.16%。 截至发稿，新产业市值为541亿元。 ...

深圳市新产业生物医学工程股份有限公司 证券代码：300832 证券简称：新产业 公告编号：2025-072 | 产品名称 | | 注册 分类 | 注册证编号 | | | 注册证有效期 | | | 适用范围 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 心脏型脂 | 肪酸 | | | | | | | | 本试剂盒用于体外定量测定 人血清或血浆中心脏型脂肪 | | 结合蛋白 | 测定 | | 粤械注准 | 2025 | 年 | 09 | 月 12 | 日至 | | | | | Ⅱ类 | | | | | | | 酸结合蛋白的含量。临床上 | | 试剂盒（胶乳免 | | | 20252401250 | 2030 | 年 | 09 | 月 11 | 日 | | | | | | | | | | | | 用于急性心肌梗死的辅助诊 | | 疫比浊法） | | | | | | | | | 断。 | 一、获证产品的具体情况 急性心肌梗死（AMI）是由于冠状动脉急性阻塞导致相应心肌区域供血不足， 使心肌坏死的影响生命的疾病。全球范围内，AMI 发 ...